PALI
PALI
NASDAQ · Biotechnology

Palisade Bio Inc

$1.86
+0.11 (+6.29%)
As of Apr 1, 2:21 PM ET ·
Financial Highlights (FY 2025)
Revenue
116.39M
Net Income
12.19M
Gross Margin
32.0%
Profit Margin
10.5%
Rev Growth
-3.2%
D/E Ratio
0.59
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 32.0% 32.0% 32.0%
Operating Margin 9.8% 12.0% 10.0%
Profit Margin 10.5% 10.1% 9.7%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 116.39M 123.33M 94.21M
Gross Profit 37.25M 39.47M 30.15M
Operating Income 11.37M 14.80M 9.44M
Net Income 12.19M 12.43M 9.10M
Gross Margin 32.0% 32.0% 32.0%
Operating Margin 9.8% 12.0% 10.0%
Profit Margin 10.5% 10.1% 9.7%
Rev Growth -3.2% +20.3% +7.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 104.47M 93.65M 105.99M
Total Equity 176.98M 160.18M 164.42M
D/E Ratio 0.59 0.58 0.64
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 16.58M 20.40M 14.08M
Free Cash Flow 11.50M 12.12M 8.26M